GRI Bio, Inc. — Form 8-K Summary
Business Context and Reporting Period
GRI Bio, Inc. filed a Form 8-K reporting a Nasdaq listing compliance matter. The report concerns the Company’s stockholders’ equity as evaluated through the quarter ended March 31, 2024, and a Nasdaq staff determination received on May 21, 2024.
Key Financial and Listing Metrics
- The Company reported more than $2.5 million in stockholders’ equity in its Form 10-Q for the quarter ended March 31, 2024.
- Nasdaq nevertheless determined that the Company had not regained compliance with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b), after considering the Company’s historical cash burn rate.
- The filing does not provide revenue, net income or loss, operating cash flow, cash balance, margins, debt, or liquidity figures.
Material Changes Versus the Prior Comparable Period
- On November 22, 2023, Nasdaq notified the Company that it did not meet the minimum stockholders’ equity requirement based on its Form 10-Q for the quarter ended September 30, 2023.
- The Company received an initial 180-calendar-day compliance period ending May 20, 2024.
- On May 21, 2024, Nasdaq issued a staff determination that the Company had not regained compliance despite reporting stockholders’ equity above $2.5 million for the quarter ended March 31, 2024.
Outlook, Contingencies, and Risks
- The Company intends to appeal the determination to a Nasdaq Hearings Panel by the May 28, 2024 deadline.
- A timely appeal will automatically stay any suspension or delisting action pending the Panel hearing, and the Company’s common stock is expected to remain listed on The Nasdaq Capital Market during that process.
- The Panel may grant an additional compliance period of up to 180 days from the staff determination.
- There is no assurance that the Panel will grant an extension or that the Company will ultimately regain compliance with all applicable Nasdaq continued-listing requirements.
- The reference to historical burn rate indicates that continued operating losses or cash usage may affect Nasdaq’s assessment of the Company’s ability to satisfy the stockholders’ equity requirement.
Investor Verification Checklist
- Verify the Company’s stockholders’ equity, accumulated deficit, cash balance, and operating cash burn in the March 31, 2024 Form 10-Q.
- Confirm whether the Company filed its appeal by May 28, 2024 and review the Hearings Panel’s decision and any extension conditions.
- Monitor subsequent filings for Nasdaq compliance, potential suspension or delisting, and any financing or capital-raising activities intended to improve stockholders’ equity or liquidity.
- Assess whether ongoing cash requirements and historical burn rate create additional financing, dilution, or going-concern risks.